RUA Life Sciences plc Stock

Equities

AOR

GB0033360586

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:24 2024-07-12 am EDT 5-day change 1st Jan Change
10.88 GBX 0.00% Intraday chart for RUA Life Sciences plc -1.14% +10.41%
Sales 2024 * 2.24M 2.92M Sales 2025 * 3.28M 4.26M Capitalization 6.75M 8.77M
Net income 2024 * -1M -1.3M Net income 2025 * - 0 EV / Sales 2024 * 1.38 x
Net cash position 2024 * 3.66M 4.75M Net cash position 2025 * 2.95M 3.83M EV / Sales 2025 * 1.16 x
P/E ratio 2024 *
-2.51 x
P/E ratio 2025 *
-7.25 x
Employees 48
Yield 2024 *
-
Yield 2025 *
-
Free-Float 54.97%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.14%
Current month-1.14%
1 month+1.16%
3 months-9.38%
6 months-16.98%
Current year+10.41%
More quotes
1 week
10.52
Extreme 10.5165
11.40
1 month
9.89
Extreme 9.885
11.50
Current year
8.50
Extreme 8.5
14.30
1 year
8.50
Extreme 8.5
58.75
3 years
8.50
Extreme 8.5
168.00
5 years
8.50
Extreme 8.5
180.00
10 years
8.00
Extreme 8
180.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 11-10-20
Director of Finance/CFO - 21-11-30
Director/Board Member 71 16-10-30
Members of the board TitleAgeSince
Chief Executive Officer 55 11-10-20
Director/Board Member 73 -
Director/Board Member 57 21-01-17
More insiders
Date Price Change Volume
24-07-12 10.88 0.00% 108,722
24-07-11 10.88 0.00% 181,250
24-07-10 10.88 -1.14% 98,793
24-07-09 11 -2.22% 44,556
24-07-08 11.25 +2.27% 205,627

Delayed Quote London S.E., July 12, 2024 at 11:35 am EDT

More quotes
RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise